With the support of a new $1.58 million grant from the National Institutes of Health (NIH), University at Buffalo researchers aim to develop a targeted treatment to prevent communication between cancer cells.

One hundred thirty-three students will take their first step toward becoming pharmacists when they participate in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences Annual White Coat Ceremony.

University at Buffalo researchers have assembled a team of three antibiotics that, together, are capable of eradicating E. coli carrying mcr-1 and ndm-5 — genes that make the bacterium immune to last-resort antibiotics.